Ambrx Biopharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DARWIN GLOBAL MANAGEMENT, LTD. | 02/14/2024 | 16.69 M | $237.65 M | 100.00% | 26.81% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2024 | 11.23 M | $159.93 M | 100.00% | 18.04% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2024 | 4.35 M | $61.98 M | 100.00% | 6.99% |
| D. E. SHAW & CO., INC. | 02/14/2024 | 4.24 M | $60.38 M | 100.00% | 6.81% |
| DEEP TRACK CAPITAL, LP | 02/14/2024 | 3.71 M | $52.84 M | 100.00% | 5.96% |
| NEXTECH INVEST LTD. | 02/14/2024 | 3.13 M | $44.56 M | 100.00% | 5.03% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2024 | 2.15 M | $30.68 M | 100.00% | 3.46% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2024 | 2.10 M | $29.90 M | 100.00% | 3.37% |
| VR ADVISER, LLC | 02/14/2024 | 2.07 M | $29.48 M | 100.00% | 3.33% |
| CITADEL ADVISORS LLC | 02/14/2024 | 2.04 M | $29.08 M | 100.00% | 3.28% |
| FMR LLC | 02/13/2024 | 1.47 M | $20.99 M | 100.00% | 2.37% |
| VANGUARD GROUP INC | 03/11/2024 | 1.40 M | $19.93 M | 100.00% | 2.25% |
| WOODLINE PARTNERS LP | 02/14/2024 | 1.26 M | $17.87 M | 100.00% | 2.02% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/16/2024 | 1.08 M | $15.44 M | 100.00% | 1.74% |
| WUXI APPTEC CO., LTD. | 02/06/2024 | 1.00 M | $14.24 M | 100.00% | 1.61% |
| BLACKROCK INC. | 02/13/2024 | 501,604 | $7.14 M | 100.00% | 0.81% |
| GHOST TREE CAPITAL, LLC | 02/14/2024 | 475,000 | $6.76 M | 100.00% | 0.76% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 432,709 | $6.16 M | 100.00% | 0.70% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 399,648 | $5.69 M | 100.00% | 0.64% |
| ALLY BRIDGE GROUP (NY) LLC | 02/14/2024 | 385,383 | $5.49 M | 100.00% | 0.62% |
| FEDERATED HERMES, INC. | 01/31/2024 | 330,949 | $4.71 M | 100.00% | 0.53% |
| MACQUARIE GROUP LTD | 02/14/2024 | 300,000 | $4.27 M | 100.00% | 0.48% |
| ORBIMED ADVISORS LLC | 02/14/2024 | 296,000 | $4.22 M | 100.00% | 0.48% |
| JANE STREET GROUP, LLC | 02/15/2024 | 295,642 | $4.21 M | 100.00% | 0.47% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2024 | 263,743 | $3.76 M | 100.00% | 0.42% |
| ALLIANCEBERNSTEIN L.P. | 02/14/2024 | 258,364 | $3.68 M | 100.00% | 0.42% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 02/12/2024 | 207,500 | $2.95 M | 100.00% | 0.33% |
| HIGHVISTA STRATEGIES LLC | 02/14/2024 | 203,122 | $2.89 M | 100.00% | 0.33% |
| BARCLAYS PLC | 02/15/2024 | 199,950 | $2.85 M | 100.00% | 0.32% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2024 | 150,000 | $2.14 M | 100.00% | 0.24% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/14/2024 | 140,842 | $2.01 M | 100.00% | 0.23% |
| TD ASSET MANAGEMENT INC | 02/12/2024 | 140,256 | $2.00 M | 100.00% | 0.23% |
| STEMPOINT CAPITAL LP | 02/13/2024 | 126,101 | $1.80 M | 100.00% | 0.20% |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | 02/14/2024 | 88,925 | $1.27 M | 100.00% | 0.14% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2024 | 87,678 | $1.25 M | 100.00% | 0.14% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 81,157 | $1.16 M | 100.00% | 0.13% |
| PERCEPTIVE ADVISORS LLC | 02/26/2024 | 78,811 | $1.12 M | 100.00% | 0.13% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2024 | 77,472 | $1.10 M | 100.00% | 0.12% |
| CITADEL ADVISORS LLC | 02/14/2024 | 76,000 | $1.08 M | 100.00% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2024 | 70,200 | $999,648 | 100.00% | 0.11% |
| ROYAL BANK OF CANADA | 02/14/2024 | 70,094 | $998,000 | 100.00% | 0.11% |
| CONNECTIVE CAPITAL MANAGEMENT, LLC | 05/17/2024 | 58,189 | $828,611 | 100.00% | 0.09% |
| HEALTHINVEST PARTNERS AB | 01/30/2024 | 57,847 | $823,741 | 100.00% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2024 | 54,600 | $777,504 | 100.00% | 0.09% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 53,900 | $768,000 | 100.00% | 0.09% |
| NWI MANAGEMENT LP | 02/15/2024 | 53,645 | $764,000 | 100.00% | 0.09% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/14/2024 | 52,781 | $751,601 | 100.00% | 0.08% |
| STATE STREET CORP | 02/14/2024 | 50,015 | $712,214 | 100.00% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2024 | 49,203 | $700,651 | 100.00% | 0.08% |
| ALTITUDE CREST PARTNERS INC. | 02/14/2024 | 43,100 | $613,744 | 100.00% | 0.07% |
Ambrx Biopharma Inc.institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Ambrx Biopharma Inc.. The most heavily invested institutionals were:
Cutler Group LLC / CA: 0
Altitude Crest Partners Inc.: 0
INNOVIS ASSET MANAGEMENT LLC: 31,137
QP WEALTH MANAGEMENT, LLC: 0
BerganKDV Wealth Management, LLC: 100
Marshall Wace North America L.P.: 0
102.96% of Ambrx Biopharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 31,237 shares in the last 24 months. This purchase volume represents approximately $874,636 in transactions.